PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,863,077 | -30.1% | 165,114 | -26.9% | 0.00% | 0.0% |
| Q2 2023 | $4,095,537 | -41.6% | 226,023 | -14.2% | 0.00% | 0.0% |
| Q1 2023 | $7,009,446 | +146.1% | 263,513 | +78.8% | 0.00% | 0.0% |
| Q4 2022 | $2,848,411 | +32.9% | 147,357 | +43.7% | 0.00% | – |
| Q3 2022 | $2,143,000 | -38.0% | 102,566 | -76.2% | 0.00% | -100.0% |
| Q2 2022 | $3,454,000 | +245.4% | 431,224 | +202.2% | 0.00% | – |
| Q1 2022 | $1,000,000 | -24.1% | 142,685 | +46.2% | 0.00% | – |
| Q4 2021 | $1,318,000 | +136.2% | 97,628 | +195.3% | 0.00% | – |
| Q3 2021 | $558,000 | -24.5% | 33,066 | +30.2% | 0.00% | – |
| Q2 2021 | $739,000 | +27.6% | 25,406 | +72.6% | 0.00% | – |
| Q1 2021 | $579,000 | +41.2% | 14,717 | -18.5% | 0.00% | – |
| Q4 2020 | $410,000 | -71.9% | 18,065 | -59.9% | 0.00% | – |
| Q2 2020 | $1,461,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |